Fair Value Measurement (Tables)

12 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Schedule of Liabilities Related to Warrants

	As of March 31, 2019
	Level 1		Level 2		Level 3		Total
Assets
Marketable securities -				-		-
Circassia Pharmaceuticals plc (Note 9)	$	-				5,649,486		5,649,486
Mutual funds		893,181		-		-		893,181
	$	893,181	$	-	$	5,649,486	$	6,542,667

	As of March 31, 2018
	Level 1		Level 2		Level 3		Total
Assets
Mutual funds	$	8,304,392		-		-		8,304,392

	As of March 31, 2018
	Level 1		Level 2		Level 3		Total
Liabilities
Liabilities related to warrants	$	-	$	-	$	5,677,934	$	5,677,934